Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 13

Results For "CAS"

2219 News Found

Trialbee and Castor partner to simplify enrolment to clinical trials globally
Healthcare | September 22, 2021

Trialbee and Castor partner to simplify enrolment to clinical trials globally

Industry leaders to increase patient access to clinical research and scale remote enrollment of participants for trial sponsors to promote increased health equity


Mylab Discovery Solutions acquires Sanskritech in an all-cash deal
Clinical Trials | September 20, 2021

Mylab Discovery Solutions acquires Sanskritech in an all-cash deal

The investment will be used to develop affordable Point of Care labs with 70+ tests. Mylab will start deploying systems with its lab partners from Nov 2021


Mylab Discovery Solutions acquires Sanskritech in an all-cash deal
Clinical Trials | September 20, 2021

Mylab Discovery Solutions acquires Sanskritech in an all-cash deal

The investment will be used to develop affordable Point of Care labs with 70+ tests. Mylab will start deploying systems with its lab partners from Nov 2021


Caspian Debt to fund healthcare companies, partners Samridh
Startup | August 20, 2021

Caspian Debt to fund healthcare companies, partners Samridh

Caspian Debt has in principle committed up to Rs 35 crores to SAMRIDH’s commercial debt investment pool


SPI Pharma partners Azelis Americas
Supply Chain | August 07, 2021

SPI Pharma partners Azelis Americas

In the agreement, Marcor, an Azelis Americas company, will distribute the SPI Pharma product lines in the United States, and Azelis Canada Pharma Division will be responsible for the Canadian marketplace


Meddo acquires Doxper in a cash and stock deal
Healthcare | August 03, 2021

Meddo acquires Doxper in a cash and stock deal

This deal makes Meddo, one of the largest health-tech players in India


Sun Pharma signs Cassiopea for license and supply agreements
News | July 27, 2021

Sun Pharma signs Cassiopea for license and supply agreements

Winlevi has been approved by the United States FDA as a novel drug with a unique mechanism of action for the topical treatment of acne in patients 12 years and older


Piramal Enterprises cashing in on opportunities: ICICI Securities
News | March 02, 2021

Piramal Enterprises cashing in on opportunities: ICICI Securities

PEL will explore the PLI scheme and apply if its beneficial.


AbbVie to acquire Apogee in $10.9 billion immunology power play
Biopharma | June 23, 2026

AbbVie to acquire Apogee in $10.9 billion immunology power play

Under the agreement, Apogee shareholders will receive $135.11 per share in cash, and the transaction has been unanimously approved by both companies’ boards


Shilpa Biologicals' PartnerPower promises real-time transparency in biologics development
Biopharma | June 23, 2026

Shilpa Biologicals' PartnerPower promises real-time transparency in biologics development

New digital platform provides global sponsors with live visibility into R&D, process development and GMP manufacturing operations, enhancing collaboration and decision-making